Accelerating Drug Development With Precision Micro-Dosing Technology

In early-stage drug development, the amount of active pharmaceutical ingredient available for formulation development is usually very limited. Aggressive timelines for initiating phase I clinical studies to evaluate safety, pharmacokinetics of the drug, and proof of concept often favors the selection of capsule dosage form. Submitted by Xcelience